Is erythromycin therapy teratogenic in humans?

Reproductive Toxicology

Volumn 20, Issue 2, 2005, Pages 209-214

  Källén, Bengt A J ^a   Olausson, Petra Otterblad ^b   Danielsson, Bengt R ^c  

^a UNIVERSITY OF LUND   (Sweden)

^b CENTRE FOR EPIDEMIOLOGY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cardiovascular defects; Epidemiology; Erythromycin; hERG; IKr; Pyloric stenosis; Teratogenicity

Indexed keywords

ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANTITUSSIVE AGENT; ANTIULCER AGENT; CEFADROXIL; CEPHALOSPORIN; CLINDAMYCIN; CONTRACEPTIVE AGENT; DOXYCYCLINE; ERYTHROMYCIN; GESTAGEN; GLUCOCORTICOID; INSULIN; METRONIDAZOLE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENICILLIN V; POTASSIUM CHANNEL; SEDATIVE AGENT; TETRACYCLINE DERIVATIVE; THYROID HORMONE;

ANTIBIOTIC THERAPY; AORTA COARCTATION; ARTICLE; BIRTH; CARDIOVASCULAR MALFORMATION; CATARACT; CHOANA ATRESIA; CLEFT PALATE; CONFIDENCE INTERVAL; CONGENITAL MALFORMATION; CONGENITAL SKIN DISEASE; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; CRYPTORCHISM; DOWN SYNDROME; DRUG EXPOSURE; DRUG USE; EAR MALFORMATION; ENCEPHALOCELE; ENDOCARDIAL CUSHION DEFECT; EYE MALFORMATION; FIRST TRIMESTER PREGNANCY; HEART ATRIUM SEPTUM DEFECT; HEART RHYTHM; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK POPULATION; HIP DISLOCATION; HUMAN; HYPOSPADIAS; INFANT; INHIBITION KINETICS; INTERVIEW; LACRIMAL DUCT OCCLUSION; LIMB MALFORMATION; MAJOR CLINICAL STUDY; MALE GENITAL SYSTEM DISEASE; MEDICAL INFORMATION; NEVUS; PATENT DUCTUS ARTERIOSUS; POLYDACTYLY; PREGNANCY; PULMONARY ARTERY STENOSIS; PYLORUS STENOSIS; RECORDING; REGISTER; REGULATORY MECHANISM; RISK; RISK ASSESSMENT; SPINA BIFIDA; STRIDOR; SYNDACTYLY; TERATOGENESIS; TONGUE DISEASE; VESICOURETERAL REFLUX; X CHROMOSOME ABERRATION;

ADULT; CONFIDENCE INTERVALS; ERYTHROMYCIN; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; INTERVIEWS; ODDS RATIO; PREGNANCY; PYLORIC STENOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TERATOGENS;

ANIMALIA;

EID: 19444367335     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2005.01.010     Document Type: Article

References (29)

1. O.P. Heinonen, D. Slone, and S. Shapiro Birth defects and drugs in pregnancy 1977 Littleton, Mass. Publishing Science Group, Inc.
2. A.E. Czeizel, M. Rockenbauer, H.T. Sørensen, and J. Olsen A population-based case-control teratologic study of oral erythromycin treatment during pregnancy Reprod Toxicol 13 1999 531 536
3. B. Källén, and P. Otterblad Olausson Maternal drug use in early pregnancy and infant cardiovascular defect Reprod Toxicol 17 2003 255 261
4. W.O. Cooper, M.R. Griffin, P. Arbogast, G.B. Hickson, S. Gautman, and W.A. Ray Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis Arch Pediatr Adolesc Med 156 2002 647 650
5. H.T. Sørensen, M.V. Skriver, L. Pedersen, H. Larsen, F. Ebbesen, and H.C. Schonheyder Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides Scand J Infect Dis 35 2003 104 106
6. W.O. Cooper, W.A. Ray, and M.R. Griffin Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis Obstet Gynecol 100 2002 101 106
7. The National Board of Health and Welfare, Centre for Epidemiology. Research Report from EpC. 2003. The Swedish Medical Birth Registry - a summary of content and quality, Stockholm, 2003. http://www.sos.se/FULLTEXT/112/2003- 112-3/2003-112-3.pdf.
8. The National Board of Health and Welfare, Centre for Epidemiology. Research Report from EpC. 2003. Registration of Congenital Malformations in the Swedish Health Registers, 2004. http://www.sos.se/plus/dokinfo.asp?valPubl_id= 2004-112-1.
9. R. Webster, D. Leishman, and D. Walker Towards a drug concentration effect for QT prolongation and torsades de pointes Curr Opin Drug Discovery Dev 5 2002 116 126
10. W.A. Volberg, B.J. Koci, W. Su, J. Lin, and J. Zhou Blockade of human cardiac potassium channel human ether a go-go-related gene (HERG) by macrolide antibiotics J Pharmacol Exp Ther 302 2002 320 327
11. S.J. Stanat, C.G. Carlton, W.J. Crumb Jr., K.C. Agrawal, and C.W. Clarkson Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel Mol Cell Biochem 254 2003 1 7
12. P. Milberg, L. Eckardt, H.J. Bruns, J. Biertz, S. Rantin, and N. Reinsch Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early after depolarizations and torsades de pointes J Pharmacol Exp Ther 303 2002 218 225
13. L.M. Hondeghem, and P. Hoffmann Blinded test in isolated female rabbit heart reliably identifies action potential prolongation and proarrhythmic drug importance of triangulation, reverse use dependence, and instability J Cardiovasc Pharmacol 41 2003 1 3
14. M.P. Davies, R.H. An, P. Doevendans, S. Kubalak, K.R. Chien, and R.S. Kass Developmental changes in ionic channel activity in the embryonic murine heart Circ Res 78 1996 15 25
15. L. Wang, Z.P. Feng, C.S. Kondo, R.S. Sheldon, and H.J. Duff Developmental changes in the delayed rectifier K+ channels in mouse heart Circ Res 79 1996 79 85
16. Y. Ban, R. Konishi, K. Kawana, T. Nakatsuka, T. Fuji, and J.M. Manson Embryotoxic effects of L-691,121, a class III antiarrhythmic agent, in rats Arch Toxicol 69 1994 65 71
17. S.G. Spence, C. Vetter, and C.M. Hoe Effects of the class III antiarrhythmic, dofetilide (UK-68,798) on the heart rate of midgestation rat embryos in vitro Teratology 49 1994 282 292
18. T.A. Marks, and R.D. Terry Developmental toxicity of ibutilide fumarate in rats after oral administration Teratology 54 1996 157 164
19. W.S. Webster, P.D. Brown-Woodman, M.D. Snow, and B.R. Danielsson Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity Teratology 53 1999 168 175
20. F. Azarbayjani, and B.R. Danielsson Embryonic arrhythmia by inhibition of HERG channels: a common hypoxia-related teratogenic mechanism for antiepileptic drugs? Epilepsia 43 2002 457 468
21. A.C. Sköld, C. Danielsson, B. Linder, and B.R. Danielsson Teratogenicity of IKr-blocker cisapride: relation to embryonic cardiac arrhythmia Reprod Toxicol 16 2002 333 342
22. A.C. Sköld, K. Wellfelt, and B.R. Danielsson Stage-specific skeletal and visceral defects of the I(Kr)-blocker almokalant: further evidence for teratogenicity via a hypoxia-related mechanism Teratology 64 2001 292 300
23. B.R. Danielsson, A.C. Sköld, and F. Azarbayjani Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage Curr Pharm Des 7 2001 787 802
24. C. Abrahamsson, M. Palmer, B. Ljung, G. Duker, C. Bäärnhielm, and L. Carlsson Induction of rhythm abnormalities in the fetal rat heart: A tentative mechanism for embryotoxic effect of the class III antiarrhythmic agent alkokalant Cardiovas Res 28 1994 337 344
25. S. Viskin Long QT syndrome and torsades de pointes Lancet 354 1999 1625 1633
26. O.C. Jaffe Hemodynamic factors in the development of the chick embryo heart Anat Rec 151 1965 69 76
27. E.F. Gilbert, H.J. Bruyere Jr., S. Ishikawa, L.M. Foulke, and S.R. Heimann Role of decreased cardiac output in isoproterenol-induced cardiovascular teratogenesis in chick embryos Teratology 21 1980 299 307
28. G.M. Rajala, R.S. Kuhlmann, and G.L. Kolesari The role of dysrhythmic heart function during cardiovascular teratogenesis in epinephrine-treated chick embryos Teratology 30 1984 385 392
29. M.L. Kirby Cardiac morphogenesis - recent research advances Pediatr Res 21 1987 219 224